In response to heightened pressure from the government and the public to lower drug prices, many of the world's largest pharma companies shelved price hikes in the U.S. in 2018. However, despite these promises, 28 pharma companies plan to hike…
Pharmacy
Walgreens and Verily, Alphabet's life sciences unit, will team up to improve health outcomes and lower the cost of care, particularly for patients with chronic conditions.
Canadian cannabis company Tilray entered a global supply and distribution agreement with Novartis' generic drug business Sandoz.
Healthcare Reform
Pfizer and GlaxoSmithKline plan to combine their consumer healthcare units in a venture to create the world's largest over-the-counter drug business, The Wall Street Journal reports.
Advertisement
Firdapse, an old, formerly inexpensive drug that treats a rare autoimmune disorder, just received a new $375,000 price tag, according to a STAT news report.
Hospital performance can be a moving target for hospital administrators due to changing regulatory pressures, reimbursement challenges and the transition from inpatient to ambulatory care.
Novartis CAR-T chief David Lebwohl is leaving the Swiss company to join Semma Therapeutics, a Cambridge, Mass.-based drugmaker developing a stem-cell cure for diabetes, according to EndPoints News.
Swiss drugmaker Novartis is looking to partner with global reinsurance companies to help health systems bear the cost of new generation, personalized therapies, according to the Financial Times.
Johnson & Johnson plans to repurchase up to $5 billion of its stock after losing more $50 billion in market value in two days of trading after a Reuters report surfaced that the drugmaker knew its baby powder contained carcinogenic…